In clinical trials, diarrhea is a common side effect, occurring in approximately 30% of patients taking Wegovy (semaglutide 2.4 mg) and 19-23% of patients taking Zepbound (tirzepatide), according to FDA prescribing information
doi:10.3390/ph17040461 McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM
As it may, histopathological examination affirmed that Moringa stenopetala seemed to have higher hepatocyte restoration
These symptoms warrant urgent CK and potassium measurement
Our quality control measures address the specific challenges of peptide manufacturing, including proper handling of the C-H bonds and molecular structures
If pruritus is prominent, non-sedating antihistamines may provide relief, though evidence for their efficacy in this specific context is limited